Two common forever chemicals linked to higher incidence of ER-negative breast cancer
Women with higher blood levels of two common per- and polyfluoroalkyl substances, also familiarly known as PFAS, were more likely to develop estrogen receptor-negative, or ER-negative, breast cancer, according to a new study by the National Institutes of Health (NIH), part of the U.S. Department of Health and Human Services (HHS).
Read original article on The Medical News →Related news
-
Crigler-Najjar syndrome: Gene therapy maintains its efficacy four years after treatment
United Kingdom
-
This weightlifting technique can help older adults stay fit and independent as they age
United Kingdom
-
Digital program boosts positive experiences for Chinese-American dementia caregivers
United Kingdom
-
Drug discovery by scientists joins world's largest trial of Parkinson's treatments
United Kingdom
-
AI-powered smartwatch detects high blood pressure with sensitivity similar to office screening
United Kingdom
-
New research identifies promising strategy to support eating disorder recovery for adults with autism
United Kingdom
-
Genetic variant may increase the risk of pneumonia
United Kingdom
-
Metformin may lower risk of long COVID or death by 53% when prescribed early
United Kingdom